1. Predictive Factors of Response to Intensive Decongestive Physiotherapy in Upper Limb Lymphedema After Breast Cancer Treatment: a Cohort Study

   • Stéphane Vignes
   • Raphaël Porcher
   • Alain Dupuy

   OriginalPaper 03 June 2006 Pages: 1 - 6

2. In vitro and in vivo Evaluation of ¹¹¹In-labeled E. coli Heat-Stable Enterotoxin Analogs for Specific Targeting of Human Breast Cancers

   • Michael F. Giblin
   • Hariprasad Gali
   • Leonard R. Forte

   Preclinical study 25 May 2006 Pages: 7 - 15

3. Levels of circulating regulatory CD4⁺CD25⁺ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine^★

   • Matthew T. Hueman
   • Alexander Stojadinovic
   • George E. Peoples

   OriginalPaper 07 June 2006 Pages: 17 - 29

4. Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA?

   • Takanori Kawaguchi
   • Hiroshi Takazawa
   • Seiji Igarashi

   Preclinical study 05 June 2006 Pages: 31 - 43

5. Trends of breast cancer incidence and risk factor prevalence over 25 years

   • Gertraud Maskarinec
   • Yang Zhang
   • Laurence N. Kolonel

   Epidemiology 03 June 2006 Pages: 45 - 55

6. A phase II study of neoadjuvant docetaxel plus doxorubicin (KBCS-01) in stage II, III breast cancer

   • Sehwan Han
   • Sung Bae Kim
   • Hee-Suk Park

   OriginalPaper 05 June 2006 Pages: 57 - 61

7. Presence of Epithelial Cells in Nipple Aspirate Fluid is Associated with Subsequent Breast Cancer: a 25-Year Prospective Study

   • Gertrude Case Buehring
   • Amy Letscher
   • Adeline J. Hackett

   Epidemiology 10 May 2006 Pages: 63 - 70

8. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas

   • David Sarrió
   • Socorro María Rodríguez-Pinilla
   • José Palacios

   Preclinical study 15 March 2006 Pages: 71 - 79

9. Effect of Vinca alkaloids on ERα levels and Estradiol-induced responses in MCF-7 cells

   • Carlos Martínez-Campa
   • Pedro Casado
   • Sofía Ramos

   Preclinical study 23 March 2006 Pages: 81 - 89

10. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype

    • Füsun Baba
    • Kathryn Swartz
    • Andreas Friedl

    Preclinical study 25 April 2006 Pages: 91 - 98

11. Pathology of borderline HER-2/neu breast carcinoma: a biologically distinct phenotype

    • Jeffrey L. Killeen
    • Anna Ortega-Lopez
    • Jennifer B. Fu

    Preclinical study 15 March 2006 Pages: 99 - 108

12. Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese

    • Shun-Jen Chang
    • Ming-Feng Hou
    • Li-Yu Tsai

    Epidemiology 05 June 2006 Pages: 109 - 113

13. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic fmolecular markers

    • F. Millanta
    • S. Citi
    • A. Poli

    Preclinical study 15 March 2006 Pages: 115 - 120